Sino-Biocan
About:
Sino-Biocan focuses on the research and development of domestic tools in the field of cell and gene therapy.
Website: http://www.sino-biocan.com/
Top Investors: Dalton Venture, Sinovation Ventures, Breakthrough Capital, Grand Flight Investment, Neovision Capital
Description:
Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization.
Total Funding Amount:
200M CNY
Headquarters Location:
Beijing, Beijing, China
Founded Date:
2013-01-01
Contact Email:
info(AT)sinobiocan.com
Founders:
Number of Employees:
Last Funding Date:
2024-03-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai